Episode 21: Scion Life Sciences' Aaron Kantoff

episode

BioVenture VoiCes with Chris Garabedian not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

9AM ET 09/18/2026 Newscast 3 min · 18 Sep 2026 · Fox News Hourly Update

The MBA Means Almost Nothing to Her. Here's What Does Pt. 3 5 min · 18 Sep 2026 · The Best 5 Minute Wine Podcast

The Privacy Paradox_ Is Convenience Worth the Cost 2 min · 18 Sep 2026 · Conspiracy Theories Exploring The Unseen

Digital Hearts_ The Rise of AI Companionship 2 min · 18 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Swipe Trap_ Is Modern Dating Killing Connection 3 min · 18 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Hidden Cost of Silence_ The Loneliness Crisis Part 2 (2) 2 min · 18 Sep 2026 · Conspiracy Theories Exploring The Unseen

Report any issue

Source

Recorded16 Jun 2025

Publisheranchor.fm ↗

Handlerec:1031918

Show notes

Aaron Kantoff describes the road on the public markets side that eventually led him to venture, and recalls successful investments he helped lead at firms like Apple Tree Partners and Medicxi, such as Stoke Therapeutics, Akero Therapeutics, Centessa Pharmaceuticals, and RayzeBio. He discusses founding Scion with his partner, Samuel Hall, and describes raising their first fund and how the firm has a longer outlook than is traditionally thought of in venture.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in